Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee BlockagesLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical...
NEWTON, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic...
EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for the treatment of ambulatory individuals with Duchenne muscular...
Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the...
DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The global Patient Registry Software Market, valued at US$2.06 billion in 2024 stood at...
ProsperityEHR's platform streamlines operational work, enhances patient outcomes, and empowers growth for behavioral health providers, including those with specific specializations...
The Healthcare Consulting Services Market presents strong growth opportunities, especially in regions like North America and Asia-Pacific. Market drivers such...
Collaboration will focus on hospitals that would benefit from operating room intelligence to reduce downtime and improve the patient experience...
Philips and Epic Aura Integration July 24, 2025 Philips will now offer the largest cardiac care portfolio through Epic’s Aura...
WALTHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a...
Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion)Regulatory submissions underway for...
AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST. LOUIS, July 23, 2025 /PRNewswire/...
NEW DELHI, July 23, 2025 /PRNewswire/ -- According to MarkNtel Advisors, the Global Data Center Solutions Market is projected to grow from...
PLEASANTON, Calif., July 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20...
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first...
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first...
HOUSTON and SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to...
SHORT HILLS, N.J. , July 22, 2025 /PRNewswire/ -- Doceree, the world's first global network for programmatic HCP engagement, has announced...
MarketNewsUpdates News Commentary NEW YORK, July 22, 2025 /PRNewswire/ -- According to a report from Research And Markets, the AI...
Comprehensive evaluation reiterates the company's commitment to data security and transparency NEW YORK, July 22, 2025 /PRNewswire/ -- Red Sky Health,...